Open Access Case Report Article ID: JCMC-3-130

    Direct Aortic Evolut R Implantation as Valve-In-Valve in a Patient Affected by Leriche Syndrome

    Pierre Dahdah, Giuseppe Bruschi* and Victor Jebara

    Transcatheter aortic valve implantation (TAVI) is an appropriate therapy to treat elderly patients with severe aortic stenosis considered high-risk surgical candidates. The safety and effectiveness of TAVI have been demonstrated in numerous observational clinical studies, national registries and also in controlled randomized trial [1,2].

    The less invasive approach should be considered the transfemoral one, nevertheless a number of patients that are referred for TAVI are not eligible for trans-femoral access due to calcification, vascular narrowing, or tortuosity of ileo-femoral arteries. For them, the transapical, subclavian, or direct aortic approaches may be a suitable alternative. The choice of alternative access should be determined by the heart team based on anatomic characteristics and clinical status of the patient.

    We report the case of a 75-year-old female affected by Leriche syndrome who successfully underwent valve-in-surgical valve TAVI, through a direct aortic approach, with a Medtronic CoreValve Evolut R.

    Keywords: Transcatheter valve implantation; Surgery; Aortic; Aortic valve disease

    Published on: Sep 28, 2016 Pages: 38-40

    Full Text PDF Full Text HTML DOI: 10.17352/2455-2976.000030
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat


    Case Reports

    Pinterest on JCMC

    Help ? Google Reviews 11